Cytokinetics, Incorporated
USD80.20
+0.02 (+0.02%)
CEO
Robert I. Blum
IPO Date
2004-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$80.81
Prev. Close
$80.18
Day Low
$79.71
Day High
$81.24
52W Low
$32.89
52W High
$88.31
Market Cap
$9.98B
Volume
0.62M
| 75 |
| $82.62 |
| 16 Jul 2026 | Kaye Edward M. MD | director | A-Award | Acquired | 151 | $82.62 |
| 16 Jul 2026 | HENDERSON JOHN T | director | A-Award | Acquired | 272 | $82.62 |
| 16 Jul 2026 | Harrington Robert Arthur | director | A-Award | Acquired | 151 | $82.62 |
| 16 Jul 2026 | Daly James M | director | A-Award | Acquired | 151 | $82.62 |
| 14 Jul 2026 | Blum Robert I | director, officer: President & CEO | S-Sale | Disposed | 7,490 | $82.02 |
| 14 Jul 2026 | Blum Robert I | director, officer: President & CEO | M-Exempt | Acquired | 7,490 | $10.60 |
| 14 Jul 2026 | Blum Robert I | director, officer: President & CEO | M-Exempt | Disposed | 7,490 | $10.60 |
| 7 Jul 2026 | Malik Fady Ibraham | EVP Research & Development | M-Exempt | Acquired | 3,500 | $7.80 |
| $1,001 - $15,000 |